We describe a peptide sequencing procedure which can be used to verify an ami no acid sequence which is derived from a nudeotide sequence. One first labels the protein with a %-and a '^C-labelled amino acid and then cleaves the protein into a set of peptides using a cleavage reaction specific for a particular amino acid residue. Finally one performs Edman degradations on the whole mixture of peptides. The released amino acids reflect the combined aminoterminal amino acid sequences of all the peptides that have been formed by the cleavage reaction. The data can therefore be used to check a deduced sequence simultaneously at several regions of the polypeptide chain. We have applied this sequencing procedure to verify the amino acid sequence deduced from the 26S RNA of Semliki Forest virus.
INTRODUCTION
Semliki Forest virus (SFV) is a simple enveloped virus which is widely used as a model system to study the structure and biosynthesis of plasma membrane proteins (1, 2) . The structural proteins of SFV, the nucleocapsid protein (C, MW 30K) and the three membrane proteins (E3, MW 10K; E2, MW 50K and El, MW 50K) are sequentially translated from a 26S RNA molecule using a single initiation site, and are released through proteolytic cleavages (1, 3) .
The 26S mRNA is homologous with the 3' end of the viral genome (42S RNA) and both RNA molecules are produced in large amounts in infected cells (4) .
We have recently determined the complete nudeotide sequence of the 26S RNA and from that we deduced the amino acid sequence of all the structural proteins (5, 6) . The coding regions of the individual viral proteins were localized on the polycistronic 26S mRNA using amino-and carboxyterminal amino acid sequence data reported by others (7, 8, 9) and also obtained by us (unpublished). Here we report how the deduced amino acid sequences have been confirmed through sequence analyses of peptides derived from the viral 3 14 proteins. Our approach has been to label the protein with a H-and a C labelled amino acid, cleave the protein on the carboxyterminal side of methionyl residues with cyanogen bromide and finally sequence the amino terminal amino acids of all peptides at the same time in an automatic sequencer. The pattern of radioactivity of the released anilino thiazolinone amino acids will reflect the combined amino terminal ""inn acid sequences of all peptides. The data can therefore be used to check a deduced amino acid sequence simultaneously at several different regions.
Comparisons of the radioactivity patterns obtained from the viral proteins with the amino acid sequences derived from the primary structure of the 26S RNA in all three reading frames confirmed the sequence deduced from one of the frames.
MATERIALS AND METHODS

Preparation of Radioactive Virus
Baby hamster kidney cells, grown as a monolayer in two Falcon bottles (75 cm , each containing approx. 3 x 10 cells), were infected with SFV using about 50 plaque forming units per cell in 2 ml minimum essential medium (MEM, Orion, Helsinki). One hour after infection the medium was replaced by 7 ml of MEM which lacked the amino acid used for labelling and contained 1 mCi 3 14 of the radioactive amino acid precursor (3,4 - 
H(N)L-Trp, New England Nuclear NEN) and actinomycin D (1 ug/ml). Seven hours after infection the medium was 4 collected and freed from cell debris by centrifugation for 20 min at 10 rpm at + 4°C in a Sorvall HB-4 rotor. The virus particles in the supernatant were 4 recovered from the pellet by further centrifugation for 60 min at 4 x 10 rpm and + 4°C in a Beckman SW 40 rotor, taken up into 150 pi of TN buffer (50 mM Tris, pH 7.4, 100 mM NaCl) and layered on a 500 pi discontinuous sucrose gradient comprising 50 ul 50Z (w/v), 50 ul, 45Z, 100 ul 40Z, 100 yl 35Z, 100 pi 30Z and 100 pi 25Z sucrose. After centrifugation for 5 hrs at 37 x 10 rpm and + 4 C in a Beckman SW 50 rotor fitted with adaptors for 600 pi tubes, the virus particles, which banded at the 40Z -45Z sucrose interphase, were collected from above (in a volume of 75 -100 pi) and stored at -80 C.
Amino Acid Analyses of Labelled Proteins
A sample (approx. 1 x 10 cpm) of each labelled virus preparation was mixed with the same amount (in cpm) of either a H labelled amino acid 14 mixture (NEN) or a C labelled amino acid mixture (NEN), hydrolyzed under reduced pressure for 24 hrs at 110 C with 6M HC1 and analysed for radioactive amino acids in a Biotronik LC 6000 amino acid analyser. The outlet from the ion exchange column was connected to a home-made fraction collector fitted for scintillation vials. About 130 fractions, each containing 0.5 ml, were collected in each analysis and these were mixed with 10 ml of a Triton X-10O-based scintillation fluid (Rotizint 22; Roth, Karlsruhe) and then analysed 3 14 for H and C radioactivity in a Nuclear Chicago mark III liquid scintillation counter.
Isolation of Viral Proteins
A mixture of a lA C labelled (1-2 x 10 & cpm) and a 3 H labelled (2-3 x 10 6 cpm) virus preparation in about 50 ul was mixed with an equal volume of electrophoresis buffer (10) containing 2Z (w/v) SDS but no reducing agent, and incubated at 95°C for 5 min before electrophoresis on a 10-15Z acrylamide gel (10) . The proteins were localized by autoradiography for 4-8 hrs using
Kodak X-Omat film (11) , cut out and eluted into 2 ml H.O containing 0.1Z formic acid and 100 ug apomyoglobin (Sperm whale, Beckman Instruments) by shaking at 37 C for 24 hrs. The eluate was filtered through glass wool to remove gel pieces and then lyophilized.
Cyanogen Bromide Cleavage
For cyanogen bromide cleavage, the eluted and lyophilized proteins (1-10 x 10 cpm) were taken up into 0.5 ml 70Z formic acid containing 10 mg cyanogen bromide (Eastman Kodak)and 1.55 mg apomyoglobin. After incubation for 21 hrs at 21 C in the dark, the samples were diluted with 9 volumes of H_0 and freeze-dried. Control samples were incubated in the formic acid solution without cyanogen bromide.
Automatic Amino Acid Sequencing
Automatic Edman degradations were performed in a Beckman C sequencer using a modification of the 0.1 M Quadrol program described by Brauer et al. (12) . Protein and peptide samples were taken up into 300 yl trifloroacetic o acid and then sequenced in the presence of 3 mg Polybrene (Sigma). Apomyoglobin (2 mg) was added to the protein samples prior to sequencing. The anilino thiazolinone amino acids released by the degradation procedure were 3 14 identified by measuring the H and C radioactivity in the chlorobutane extracts. These were dried under a stream of nitrogen, taken up into 300 ul isobutanol, mixed with 5 ml of a toluene-based scintillation fluid (Rotizint II; Roth, Karlsruhe) and analysed in a liquid scintillation counter.
RESULTS
Labelling of Viral Proteins with Radioactive Amino Acids
All our sequence data were obtained by micro-sequencing radioactively labelled viral proteins. The proteins were labelled in vivo by adding a radioactive precursor amino acid to the culture medium of virus-infected cells, and then isolated from purified virus particles. The possible conversion of the radioactive amino acid precursors to other amino acids during in vivo labelling was assessed by preparing an acid hydrolyzate of each labelled virus preparation, separating the amino acids by chromatography, and analysing each amino acid peak for radioactivity. Figure 1 Conversion into other amino acids was not seen using this precursor or with any of the others used for labelling (not shown). Therefore it was possible for us to localize the precursor amino acid in the sequences simply by measuring the anilino thiazolinone amino acids released during the Edman degradations for H and/or C radioactivity.
Amino-terminal Amino Acid Sequences of Peptide Mixtures
When the nucleotide sequence of the 26S RNA was translated into amino acids using either of the three possible reading frames the translation in one frame (frame 2, figure 2 ) was shown to contain a continuous sequence of 1253 sense codons whereas the translations in the other two frames were interrupted by numerous nonsense codons throughout the sequence (5, 6) . This suggested that the amino acid sequence translated in frame 2 was the correct one. In order to confirm this sequence we have compared it with amino acid sequences which have been obtained from peptides isolated from the structural proteins. In our proposed sequence we were especially concerned about possible frame shift mistakes in such regions of the sequence where one of the alternative reading frames also yielded a longer stretch of sense codons (e.g. E2 frame 3 amino acids 86 -187, El frame 1 amino acids 117 -209 and 211 -282
and El frame 3 amino acids 61 -128). Translation in the wrong frame in such a region would not include a stop codon and thus remain undetected when looking at the stop codon distribution only. The "silent" frame shift mistake might however be pointed out by specific peptide sequence data which cannot be accommodated within the proposed sequence but within a sequence translated using another frame. 1A 3 14 3 Viral proteins were isolated from a C Tyr/ H Pro, a C Lys/ H Trp and 14 a C Phe-labelled virus preparation and cleaved after methionyl residues using cyanogen bromide. The peptide mixtures of each protein were then subjected to Edman degradation in a sequencer and the labelled amino acids were 3 14 identified by measuring the chlorobutane extracts for H and C radioactivity. cycle. This removal is never complete which means that a portion of the preceeding amino acid derivate is carried over to the next degradation cycle, and, if labelled, it will be seen as a small "artificial" peak following a larger peak in the radioactivity profile. Thus, when trying to interpret our radioactivity profiles, a major problem will be to discriminate between small peaks that represent true positive signals and other small peaks that are artificial. As we did not find any easy solution to this problem we decided to classify the radioactivity data into three groups: (1) high peaks of radioactivity each of which should correspond to a labelled amino acid in the amino terminus of one or possibly several cyanogen bromide generated peptides (unshadowed peaks in Fig. 2 ), (2) low peaks of radioactivity which might represent true positive signals or artificial signals (striped in Fig. 2 ) and (3) background level of radioactivity which should correspond to unlabelled amino acids in the aminotermini of the peptides (shadowed). Peaks of radioactivity that follow larger peaks have been classified into the first group only if they are almost as high as the preceeding one, otherwise they have been classified into the second group because of the "carry over" problem described above.
The aminoterminal ends of the peptides which were sequenced in our experiments correspond to the aminoterminus of the intact protein and all regions following methionyl residues, the cleavage site of cyanogen bromide.
These regions were therefore localized on each of the three possible amino acid sequences translated from the nucleotide sequence and the positions of labelled amino acids in these regions were compared with the data obtained from the peptide sequencing experiments (see Fig. 2 ). The comparisons showed an overwhelming confirmation of the amino acid sequence translated using the second (and open) reading frame. Most of those (labelled) amino acids which should be released when sequencing cyanogen bromide generated peptides from proteins with the frame 2 amino acid sequences were actually seen as high peaks in the correct positions in the radioactivity profiles (compare encircled numbers in the amino acid sequence translated using frame 2 with the unshadowed peaks below filled in circles in Fig. 2 The shadowed peaks in the radioactivity profiles represent background level of radioactivity which correspond to unlabelled amino acids in the aminotermini of the peptides. The three horizontal lines below the radioactivity profiles of the released anilino thiozolinone amino acids in the peptide sequencing experiments represent the three possible amino-acid sequences translated from the 26S RNA nucleotide sequence with the positions for meth-ionine residues (vertical lines), nonsense codons (-S-) and Tyr, Pro, Phe, Lys and Trp residues (numbers) indicated. The numbers for Tyr, Pro, Phe, Lys and Trp refer to their position after a methionine residue or from the aminotenninu8. The numbers have been either encircled, inserted into squares or left without a frame depending on whether a positive signal, background level of radioactivity or an ambiguous signal is seen at the corresponding position of the radioactivity profile. Filled-in circles indicate where in the radioactivity profiles labelled ami no acids should be released if the peptides sequenced have been generated from a protein with an amino acid sequence deduced using the second reading frame. Two symbols have been used to indicate the expected release of the labelled amino acid from two peptides. The chlorobutan extract from cycle 16 in the '^C Tyr and "Tl Pro labelled El sequencing experiment was lost because of a handling mistake.
acids were seen as ambiguous peaks and only a single amino acid was represented by background level of radioactivity in the radioactivity profile (compare the rest of the numbers in the sequence translated using frame 2 with the radioactivity data indicated by the rest of the filled-in circles). This was a Pro residue of E3 which was expected to be released from the amino terminal peptide at the third degradation cycle. The peptide is however extremely short and apolar and therefore likely to be lost very easily during sequencing (6) . Translation of the nucleotide sequences using the first or the third reading frame yielded amino acid sequences which contained many amino acids in incorrect positions (compare numbers inserted in squares in Fig. 2 with corresponding positions in the radioactivity profiles) and very few ones in correct positions. In both of these sequences the correctly located amino acids were always found together with amino acids which were in incorrect positions and/or with stop codons, thus suggesting that these sequences are wrong.
The amino acid translation in the second reading frame is probably correct all through the sequence as all amino acids that should be present in the peptide aminotermini according to the radioactivity profiles are, with one exception, found in the proposed amino acid sequence (compare unshadowed peaks in Fig. 2 with the sequence deduced in frame 2). The single exception was a tyrosine residue which was released at the ninth degradation cycle of the El peptide sample. This finding primarily suggested to us that a silent frame shift mistake had been made at some region of the proposed amino acid sequence but we were unable to confirm this by demonstrating a tyrosine nine residues downstream from a methionyl residue or from the aminoterminus in the amino acid sequences deduced using either the first or the third reading 14 frame. Sequencing of the intact C-Tyr labelled El protein sample showed that the tyrosine residue was derived from the amino terminus of the E2 protein which slightly contaminated the El protein preparation.
The amino acid sequence which was deduced for the capsid protein has recently been completely confirmed by amino acid sequencing of this protein (13, 14) .
DISCUSSION
The recent development of techniques to rapidly sequence long DNA chains has made it much easier to establish the primary structure of a protein using DNA sequencing than by using conventional amino acid sequencing. It is, how- ways to obtain amino acid sequence data from peptides is required in future.
Important for the new verification procedures is that they should yield sequence information from a large number of peptides which are derived from different regions of the polypeptide chain. With such distributed amino acid sequence data it is possible to check the use of the correct reading frame throughout the whole sequence. The sequence information from each particular region can however be very limited as the complete amino acid sequence has already been deduced in either of the three reading frames.
We have used partial amino-terminal sequence information from peptide mixtures to confirm the amino acid sequences of the SFV proteins as deduced from the nucleotide sequence of the 26 mRKA (5, 6) . In this sequencing 3 14 approach one first labels the protein with a H and a C-labelled amino acid, and then cleaves the protein into a set of peptides using cleavage specific for a particular amino acid residue. Finally one performs Edman degradations on the whole mixture of peptides and identifies the released 3 14
H and C amino acids by analysing the chlorobutane extracts for radioactivity. The procedure will yield in a single experiment sequence-specific information from all regions of the polypeptide that are on the carboxyterminal side of the cleaved peptide bond. This information can conveniently be used for sequence comparisons with a deduced sequence. All cleavage specific amino acids are localized on the deduced sequence and the regions on their carboxyterminal side are compared with the peptide sequence data. These should be completely accommodated within the deduced sequence if this is correct. A frame shift mistake is suggested when amino acid(s) released in the peptide sequencing experiment cannbt be correctly located in the proposed sequence but in a sequence which has been translated in another frame. We have used cyanogen bromide, which cleaves peptide bonds at the carboxyterminal side of methionyl-residues, to generate peptides from the viral structural proteins, but other reagents or enyzmes can be used as well provided they are specific for one or a few amino acid residues and that they are cleaving peptide bonds with high efficiency. The sequencing experiment yields a maximum amount of information if the probability of detecting a positive signal for each label in every position will be close to 0.5, giving approxmately one bit of information for each position and separately identified radioactive label. This probability p is given by the equation: There are several advantages in using radiolabelled material in the peptide sequencing experiments: (1) the labelled amino acids released during degradation can be identified simply by their radioactivity, (2) minute amounts of protein can be used and (3) the sample need only be radiochemically pure, i.e. our sequencing approach can be used directly to study, for example, labelled proteins which have been prepared by antibody precipitations or which have been synthesized in vitro. The amount of radioactivity needed for a successful sequencing experiment is about 2 x 10 cpm (or more) per labelled 4 amino acid residue, that is about 4 x 10 cpm of radioactivity in a protein containing 400 amino acid residues 5Z of which are labelled. Unlabelled proteins can also, of course, be analyzed using the same general protocol, but more efforts must then be put into purifying the protein sample and in characterizing the released amino acid derivates (by e.g. high pressure liquid chromatography). Two groups, Shimonishi et al. (15) and Herlihy et al. (16) have recently reported the use of mass spectrometric analyses of peptide mixtures as a means to get sequence information from a polypeptide and the latter group has also used their method to verify a sequence deduced from a nucleotide sequence.
Our sequencing approach should not only be useful in the future as a simple way to confirm an amino-acid sequence deduced from a nucleotide sequence but also as a new possibility to map proteins for sequence homology.
As several regions of the polypeptide chain are analysed simultaneously when sequencing the peptide mixture of a protein, the "mapping" will be relatively insensitive to minor modifications in the polypeptide chain such as amino terminal processing (e.g. cleavage of a signal sequence) and glycosylation which usually complicates the use of conventional peptide mapping procedures.
